Kiromic Biopharma (NASDAQ: KRBP) reported Q3 2022 earnings per share (EPS) of -$22.50, up 87.5% year over year. Total Kiromic Biopharma earnings for the quarter were -$11.86 million. In the same quarter last year, Kiromic Biopharma's earnings per share (EPS) was -$12.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.